NB
VRTX icon

Northwest Bancshares’s Vertex Pharmaceuticals VRTX Stock Holding History

Northwest Bancshares’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32M Buy
10,706
+288
+3% +$128K 0.96% 29
2026
Q1 		$4.65M Sell
10,418
-218
-2% -$102K 0.93% 28
2025
Q4 		$4.82M Sell
10,636
-1,502
-12% -$647K 0.93% 31
2025
Q3 		$4.75M Buy
12,138
+935
+8% +$391K 0.79% 32
2025
Q2 		$4.99M Sell
11,203
-216
-2% -$99.5K 0.87% 29
2025
Q1 		$5.54M Sell
11,419
-302
-3% -$141K 1.02% 21
2024
Q4 		$4.72M Sell
11,721
-1,404
-11% -$651K 0.87% 28
2024
Q3 		$6.1M Sell
13,125
-2,683
-17% -$1.29M 1.04% 25
2024
Q2 		$7.41M Sell
15,808
-567
-3% -$246K 1.26% 20
2024
Q1 		$6.84M Sell
16,375
-527
-3% -$223K 1.08% 29
2023
Q4 		$6.88M Sell
16,902
-179
-1% -$66.1K 1.25% 20
2023
Q3 		$5.94M Sell
17,081
-610
-3% -$213K 1.14% 19
2023
Q2 		$6.23M Sell
17,691
-753
-4% -$254K 1.13% 21
2023
Q1 		$5.81M Buy
18,444
+357
+2% +$107K 1.12% 21
2022
Q4 		$5.22M Sell
18,087
-3,497
-16% -$1.07M 1.05% 26
2022
Q3 		$6.25M Buy
21,584
+49
+0.2% +$14.1K 1.46% 10
2022
Q2 		$6.07M Sell
21,535
-509
-2% -$136K 1.37% 12
2022
Q1 		$5.75M Sell
22,044
-1,401
-6% -$332K 1.11% 17
2021
Q4 		$5.15M Buy
23,445
+1,079
+5% +$210K 1.01% 27
2021
Q3 		$4.06M Buy
22,366
+979
+5% +$191K 0.92% 42
2021
Q2 		$4.31M Buy
21,387
+3,834
+22% +$802K 0.98% 37
2021
Q1 		$3.77M Buy
+17,553
New +$3.86M 0.89% 44

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northwest Bancshares's VRTX Position: Q2 2026 in Review

Northwest Bancshares increased its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, buying an estimated $128K and bringing the position to 10,706 shares worth $5.32M. The position accounts for 0.96% of the portfolio, ranked #29.

Northwest Bancshares first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.41M in Q2 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Northwest Bancshares held 10,706 shares of Vertex Pharmaceuticals worth $5.32M as of Q2 2026.
  • Northwest Bancshares bought 288 Vertex Pharmaceuticals shares in Q2 2026, an estimated $128K.
  • Vertex Pharmaceuticals made up 0.96% of Northwest Bancshares's portfolio in Q2 2026, its #29 holding.
  • Northwest Bancshares first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Northwest Bancshares's Vertex Pharmaceuticals position peaked at $7.41M in Q2 2024.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Northwest Bancshares's 13F filing for Q2 2026, filed 14 Aug 2026.